<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>First-generation (typical) antipsychotic medication poisoning</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">First-generation (typical) antipsychotic medication poisoning</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">First-generation (typical) antipsychotic medication poisoning</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric J Lavonas, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert G Hendrickson, MD, FACMT, FAACT</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 29, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Antipsychotic medications are primarily used to treat agitation, hallucinations, and other manifestations of psychosis arising from numerous causes, including psychiatric illnesses (schizophrenia, mania), medical illnesses (alcohol withdrawal), and neurologic disease (Alzheimer disease). When used to treat psychiatric diseases, they also aid in restructuring disordered thinking. Although their use in psychiatric disorders has been outpaced by that of atypical antipsychotic agents, they remain widely used to treat nausea. Poisoning and overdose from these drugs remains common.</p><p>Antipsychotic medications are also used to treat a number of nonpsychiatric conditions, including nausea and vomiting (<a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a>, <a class="drug drug_general" data-topicid="9820" href="/z/d/drug information/9820.html" rel="external">promethazine</a>, <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">droperidol</a>), vertigo (prochlorperazine, droperidol), itching (promethazine), migraine headache (prochlorperazine, <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a>, droperidol), Tourette's syndrome (haloperidol, <a class="drug drug_general" data-topicid="9773" href="/z/d/drug information/9773.html" rel="external">pimozide</a>), postherpetic neuralgia (<a class="drug drug_general" data-topicid="8467" href="/z/d/drug information/8467.html" rel="external">fluphenazine</a>), and hiccups (<a class="drug drug_general" data-topicid="9252" href="/z/d/drug information/9252.html" rel="external">chlorpromazine</a>).</p><p>This topic review will discuss the management of typical (ie, first generation) high and low potency antipsychotic medication poisoning  (<a class="graphic graphic_table graphicRef60456" href="/z/d/graphic/60456.html" rel="external">table 1</a>). A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef64216" href="/z/d/graphic/64216.html" rel="external">table 2</a>). Poisoning from atypical antipsychotic agents is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/304.html" rel="external">"Second-generation (atypical) antipsychotic medication poisoning"</a>.)</p><p class="headingAnchor" id="H143097898"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The US Centers for Disease Control estimates that approximately 5800 patients are treated in United States emergency departments annually for adverse effects from typical antipsychotic medication, including unintentional overdose, a rate of 26 ED visits per 10,000 outpatient prescription visits [<a href="#rid1">1</a>]. <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">Haloperidol</a> was responsible for a higher rate of ED visits (43.3 per 10,000 outpatient prescription visits) than any other psychiatric medication. In 2018, American poison control centers reported approximately 4100 exposures to phenothiazines, resulting in two deaths [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H2"><span class="h1">PHARMACOLOGY AND CELLULAR TOXICOLOGY</span><span class="headingEndMark"> — </span>Antipsychotic medications are commonly categorized as "low potency," "high potency," or "atypical" agents, though these distinctions may not be as clear as commonly perceived [<a href="#rid3">3</a>]. The typical antipsychotic agents antagonize dopamine (D) receptors in several areas of the brain, including the cortex, basal ganglia, limbic system, hypothalamus, and chemoreceptor trigger zone. The efficacy and potency of these agents is directly related to D2 receptor binding affinity [<a href="#rid4">4,5</a>]. However, not all forms of D2 receptor blockade are desirable. D2 antagonism in the mesocortical regions impairs cognition and exacerbates the negative symptoms of schizophrenia, such as avolition, anhedonia, poverty of speech, flattened affect, and social withdrawal.</p><p>The typical antipsychotic agents also block a variety of other central and peripheral nervous system receptors. Blockade of muscarinic acetylcholine receptors may cause dry mouth, tachycardia, sedation, and constipation, and can provoke episodes of urinary retention and angle-closure glaucoma [<a href="#rid4">4</a>]. Alpha-1 adrenergic receptor antagonism can cause orthostatic hypotension and reflex tachycardia. Histamine-1 receptor antagonism contributes to sedation.</p><p>Antipsychotic agents can affect cardiac ion channels. Most typical antipsychotics block the human ether-a-go-go-related gene (hERG, now more commonly referred to as KCNH2) channel, reducing the delayed inward potassium rectifier potassium current (IKr) and prolonging cardiac repolarization [<a href="#rid6">6</a>]. This is manifest on the electrocardiogram as QT interval prolongation, and, in extreme cases, this can lead to torsades de pointes (TdP) [<a href="#rid7">7-12</a>]. Although this effect is most pronounced with <a class="drug drug_general" data-topicid="9991" href="/z/d/drug information/9991.html" rel="external">thioridazine</a>, many other antipsychotic agents, including <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a>, <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">droperidol</a>, <a class="drug drug_general" data-topicid="9773" href="/z/d/drug information/9773.html" rel="external">pimozide</a>, and sertindole, have been associated with QT prolongation and TdP [<a href="#rid13">13,14</a>]. TdP risk has been well-documented in the absence of hERG binding, suggesting that other mechanisms may contribute to this syndrome [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">"Acquired long QT syndrome: Definitions, pathophysiology, and causes"</a>.) </p><p>QRS prolongation may occur due to antipsychotic medication-induced sodium channel blockade, particularly with <a class="drug drug_general" data-topicid="9991" href="/z/d/drug information/9991.html" rel="external">thioridazine</a> and mesoridazine [<a href="#rid6">6,16-18</a>]. Several antipsychotic medications, including <a class="drug drug_general" data-topicid="9773" href="/z/d/drug information/9773.html" rel="external">pimozide</a> and <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a>, block L-type calcium channels, but the relevance of this for human exposures is unclear [<a href="#rid19">19</a>].</p><p>Acute extrapyramidal syndromes (EPS), such as acute dystonic reactions and akathisia, appear to be related to an imbalance between dopamine (presumably D2) receptor antagonism and muscarinic (presumably M1) receptor antagonism in the CNS. Medications such as <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a> and <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a>, which have a high D2/M1 receptor affinity ratio, are the most likely to cause EPS. Subsequent research suggests that the kinetics of D2 receptor binding may be more important than overall binding affinity, and that serotonin 2A receptor occupancy may be protective [<a href="#rid20">20,21</a>]. M1 receptor antagonists, such as <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">diphenhydramine</a> and <a class="drug drug_general" data-topicid="9106" href="/z/d/drug information/9106.html" rel="external">benztropine</a>, and the dopamine agonist <a class="drug drug_general" data-topicid="8508" href="/z/d/drug information/8508.html" rel="external">amantadine</a> are equally effective remedies for acute EPS [<a href="#rid22">22</a>].</p><p>Although the neuroleptic malignant syndrome (NMS) has long been thought to be a centrally mediated phenomenon, some evidence suggests that antipsychotic medications directly affect skeletal muscle mitochondria, possibly uncoupling oxidative phosphorylation [<a href="#rid23">23-25</a>]. (See  <a class="medical medical_review" href="/z/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome"</a>.)</p><p>Antipsychotic medications are associated with an increased risk of sudden cardiac death, including cardiac arrest with pulseless electrical activity (PEA), and with venous thromboembolic disease [<a href="#rid26">26-28</a>]. It is unclear whether this is a result of the medications themselves or the disease being treated [<a href="#rid29">29,30</a>]. Antipsychotic medication use is associated with an increase in seizure frequency, compared with non-use [<a href="#rid31">31</a>]. Rare cases of rhabdomyolysis and massive asymptomatic creatine kinase elevation (MACKE) without rhabdomyolysis have been reported [<a href="#rid32">32,33</a>].</p><p class="headingAnchor" id="H3"><span class="h1">KINETICS</span><span class="headingEndMark"> — </span>Typical antipsychotic medications are absorbed quickly and enter the brain rapidly. As an example, the peak clinical effect of orally administered <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a> occurs within two to four hours after dosing [<a href="#rid34">34</a>]. In overdose, delayed peak serum concentrations can occur, particularly if anticholinergic effects delay gut motility.</p><p>Once absorbed, antipsychotic medications diffuse into lipophilic tissues; volumes of distribution (VD) are generally in the range of 8 to 10 L/kg, precluding removal by hemodialysis. Elimination half-lives range from 6 to 24 hours; for each agent, the range of half-lives measured varies greatly among individuals  (<a class="graphic graphic_table graphicRef51653" href="/z/d/graphic/51653.html" rel="external">table 3</a>) [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL FEATURES OF OVERDOSE</span></p><p class="headingAnchor" id="H5"><span class="h2">History</span><span class="headingEndMark"> — </span>Great variability exists in the amount of drug needed to cause signs and symptoms of overdose. In general, the elderly and people who are naive to the medications become symptomatic at lower doses. While conscious patients may give a history of overdose, many patients present obtunded and any history is provided by family, friends, first responders, and pharmacists. Not all patients with antipsychotic medication overdose have a history of psychiatric illness; patients may overdose on medications obtained from family members or others.</p><p>Acute extrapyramidal syndromes (EPS), such as akathisia and dystonic reactions, can occur with antipsychotic medication at any dose. The time to onset varies widely. In one emergency department case series, 44 percent of patients who received intravenous <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a> for migraine headache developed akathisia within one hour of administration, while an additional 3 percent developed akathisia within 48 hours [<a href="#rid36">36</a>]. The incidence of EPS from oral <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">haloperidol</a> dosing may be as high as 57 percent [<a href="#rid37">37</a>]. The onset of EPS appears to be more gradual following oral dosing: half of cases occur within 48 hours of initiation of the antipsychotic medication, and 90 percent occur within five days [<a href="#rid38">38</a>]. Extrapyramidal symptoms are rare in overdose.</p><p class="headingAnchor" id="H6"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Typical antipsychotic poisoning does not cause any pathognomonic signs. Pupils may be miotic, normal size, or mydriatic. Portions of the anticholinergic toxidrome, such as tachycardia, mild hyperthermia, dry skin, and diminished bowel sounds may be present, but this is by no means consistent or reliable. Mild hypotension may result from alpha adrenergic blockade. Profound hyperthermia suggests the neuroleptic malignant syndrome (NMS). Alterations in mental status range from mild somnolence to coma.</p><p>Akathisia is an acute psychomotor restlessness, characterized by a feeling of unease and inability to sit still. Most patients can suppress these behaviors briefly using voluntary control. Acute dystonic reactions are sustained muscular spasms, most commonly affecting the neck (30 percent), tongue (17 percent), or jaw (15 percent) [<a href="#rid38">38</a>]. Choreoathetoid movements, opisthotonus, oculogyric crisis, and respiratory dystonia are less common manifestations.</p><p class="headingAnchor" id="H7"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Patients who have overdosed on antipsychotic medication may be clinically indistinguishable from those who have overdosed on a wide variety of medications with sedative properties, including benzodiazepines, prescription insomnia medications (eg, <a class="drug drug_general" data-topicid="10057" href="/z/d/drug information/10057.html" rel="external">zolpidem</a> or <a class="drug drug_general" data-topicid="10334" href="/z/d/drug information/10334.html" rel="external">zaleplon</a>), cyclic antidepressants, skeletal muscle relaxants (eg, <a class="drug drug_general" data-topicid="9062" href="/z/d/drug information/9062.html" rel="external">baclofen</a>), centrally acting alpha 2 receptor agonists (eg, <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">clonidine</a>), anticonvulsants (eg, <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">carbamazepine</a>), and atypical antipsychotics. (See  <a class="medical medical_review" href="/z/d/html/295.html" rel="external">"Tricyclic antidepressant poisoning"</a> and  <a class="medical medical_review" href="/z/d/html/304.html" rel="external">"Second-generation (atypical) antipsychotic medication poisoning"</a> and  <a class="medical medical_review" href="/z/d/html/312.html" rel="external">"Phenytoin poisoning"</a>.)</p><p>Neither vital signs, physical examination, nor clinical course clearly distinguish cases of typical antipsychotic medication overdose from those of other sedatives. Fortunately, in the absence of cardiovascular effects, the same supportive care measures provide effective treatment for both typical antipsychotic medication overdoses and these mimics.</p><p>Many nontoxicologic syndromes can produce CNS depression, including hypoglycemia, acute hepatic failure, CNS infections, massive cerebrovascular accidents, severe electrolyte disorders, blunt head trauma, and septic or other forms of shock  (<a class="graphic graphic_table graphicRef59893" href="/z/d/graphic/59893.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/z/d/html/4824.html" rel="external">"Diagnosis of delirium and confusional states"</a> and  <a class="medical medical_review" href="/z/d/html/5104.html" rel="external">"Stupor and coma in adults"</a>.)</p><p>Because they cause anxiety and can be temporarily suppressed by reassurance and voluntary control, acute extrapyramidal syndromes are sometimes misdiagnosed as an anxiety reaction or conversion disorder.</p><p class="headingAnchor" id="H8"><span class="h1">LABORATORY EVALUATION</span><span class="headingEndMark"> — </span>No specific laboratory tests are needed to diagnose or treat typical antipsychotic medication overdose. Serum concentrations of specific antipsychotic drugs may be obtained if the diagnosis is in doubt. However, the results have little clinical value because they cannot be obtained readily and levels correlate poorly with clinical manifestations. Antipsychotic medications have been associated with hyponatremia and thus a serum sodium concentration should be measured in patients with an altered mental status or seizures [<a href="#rid39">39</a>]. Patients who develop hypotension, rhabdomyolysis, prolonged urinary retention, or neuroleptic malignant syndrome are at risk for acute kidney injury [<a href="#rid40">40</a>]. In such cases, serial measurements of creatinine and, in some cases, creatine kinase are appropriate.</p><p>Routine laboratory evaluation of the poisoned patient includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status</p><p class="bulletIndent1"><span class="glyph">●</span>Basic metabolic profile (electrolytes, renal function, and glucose) to evaluate for metabolic acidosis or acute kidney injury</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">Acetaminophen</a> and salicylate levels, to rule out these common coingestions</p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram (ECG), to rule out conduction system poisoning by drugs that effect the QRS or QTc intervals</p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy test in women of childbearing age</p><p></p><p class="headingAnchor" id="H9"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H10"><span class="h2">Airway, breathing, and circulation</span><span class="headingEndMark"> — </span>Although pure antipsychotic medication overdoses rarely cause significant respiratory depression, many patients overdose on multiple substances and require airway protection. Oxygen saturation monitoring should be performed and supplemental oxygen administered as necessary. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p>Hypotension should initially be treated with IV boluses of isotonic fluid, such as normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>. Hypotension refractory to normal saline should be treated with a direct-acting alpha-adrenergic agonist, such as <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>.</p><p>QRS prolongation may contribute to impaired circulation. As with cyclic antidepressants, QRS prolongation from acute antipsychotic intoxication is treated with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a>, 1 to 2 meq/kg IV push. Treatment of QRS prolongation with sodium bicarbonate is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/295.html" rel="external">"Tricyclic antidepressant poisoning"</a>.)</p><p>A summary table to facilitate emergency management of typical antipsychotic medication poisoning is provided  (<a class="graphic graphic_table graphicRef64216" href="/z/d/graphic/64216.html" rel="external">table 2</a>). The general management of drug poisoning is reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">General treatment and antidotal therapy</span><span class="headingEndMark"> — </span>Most patients with antipsychotic medication overdose present with CNS depression and no more than minor vital sign perturbations. These cases are easily managed with supportive care and hospitalization until signs of overdose have resolved.</p><p>Rarely, patients experience a severely symptomatic overdose. Patients with a profoundly depressed mental status or coma require aggressive intervention, including endotracheal intubation.</p><p>Seizures that occur in the setting of antipsychotic overdose or toxicity are treated with benzodiazepines. Such seizures are generally self-limited and traditional antiepileptics such as <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">phenytoin</a> are NOT indicated.</p><p>Hyperthermia, when mild, may be treated by undressing the patient or with evaporative cooling measures. Severe hyperthermia, particularly if it develops in the setting of muscular rigidity, altered mental status, and autonomic instability, raises the specter of neuroleptic malignant syndrome, and should be managed aggressively. (See  <a class="medical medical_review" href="/z/d/html/176.html" rel="external">"Severe nonexertional hyperthermia (classic heat stroke) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome"</a>.)</p><p>In patients who present with CNS depression, miosis, and an uncertain history, a trial administration of <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">naloxone</a> is warranted to exclude the possibility of opioid overdose [<a href="#rid41">41</a>]. Naloxone does not reverse the CNS depression caused by antipsychotic medication overdosage. The use and dosing of naloxone are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/300.html" rel="external">"Acute opioid intoxication in adults", section on 'Basic measures and antidotal therapy'</a> and  <a class="medical medical_review" href="/z/d/html/6504.html" rel="external">"Opioid intoxication in children and adolescents", section on 'Naloxone'</a>.)</p><p>The benzodiazepine antidote <a class="drug drug_general" data-topicid="8456" href="/z/d/drug information/8456.html" rel="external">flumazenil</a> is <strong>NOT</strong> effective for treating antipsychotic medication overdose. Because of the risk of seizures, flumazenil should <strong>NOT</strong> be administered to the patient with an unknown overdose. (See  <a class="medical medical_review" href="/z/d/html/314.html" rel="external">"Benzodiazepine poisoning", section on 'Role of antidote (flumazenil)'</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">GI decontamination</span><span class="headingEndMark"> — </span>Antipsychotic medication overdose does not permanently injure any organ. If hypoxia and aspiration pneumonitis can be prevented, patients generally do well. No study has shown that gastrointestinal (GI) decontamination with activated charcoal (AC) improves the outcome or hastens the recovery from antipsychotic overdose. Therefore, we do not recommend GI decontamination. (See  <a class="medical medical_review" href="/z/d/html/321.html" rel="external">"Gastrointestinal decontamination of the poisoned patient"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Acute extrapyramidal syndromes</span><span class="headingEndMark"> — </span>Acute extrapyramidal syndromes (EPS), such as dystonic reactions and akathisia, are treated with <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">diphenhydramine</a> (25 to 50 mg IV in adults; 0.5 to 1 mg/kg in children). <a class="drug drug_general" data-topicid="9106" href="/z/d/drug information/9106.html" rel="external">Benztropine</a> (1 to 2 mg IV in adults; 0.05 mg/kg in children over three years old with severe reaction) may be used initially, or if diphenhydramine therapy fails. Response is often dramatic and typically occurs within minutes of intravenous drug administration. Although the IV route is preferred, both diphenhydramine and benztropine may be given IM or orally. If initial treatment is successful, therapy is continued orally for two to three days to prevent recurrence.</p><p>Alternative treatments for EPS include benzodiazepines (eg, <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">lorazepam</a> 1 to 2 mg IV in adults; 0.05 mg/kg IV in children), <a class="drug drug_general" data-topicid="8508" href="/z/d/drug information/8508.html" rel="external">amantadine</a> (100 mg orally twice or three times daily in adults), or biperiden (2 mg orally in adults). At least two controlled studies have shown amantadine to be as effective as anticholinergic therapy, with fewer side effects [<a href="#rid22">22,42</a>]. <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">Propranolol</a> (20 to 40 mg initial dose) reduces involuntary movements in akathisia, but does not reduce anxiety [<a href="#rid43">43</a>]. A randomized trial of 13 patients with acute akathisia from antipsychotic medications reported a benefit from <a class="drug drug_general" data-topicid="10013" href="/z/d/drug information/10013.html" rel="external">trazodone</a> (100 mg/day orally in adults) [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H14"><span class="h2">QT interval prolongation</span><span class="headingEndMark"> — </span>Although many typical antipsychotic medications prolong the QT interval, torsades de pointes (TdP) is uncommon. Management of QT prolongation consists of cardiac monitoring and correction of electrolyte disorders, particularly hypokalemia and hypomagnesemia. Intravenous potassium infusion was found to correct drug related QT prolongation in an observational study of 12 subjects [<a href="#rid45">45</a>]. However, prophylactic administration of potassium to patients without hypokalemia is not advised. (See  <a class="medical medical_review" href="/z/d/html/2297.html" rel="external">"Clinical manifestations and treatment of hypokalemia in adults"</a>.)</p><p>Should polymorphic ventricular tachycardia (VT) occur, it can be treated with <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> (1 to 2 g IV), overdrive pacing, <a class="drug drug_general" data-topicid="8578" href="/z/d/drug information/8578.html" rel="external">isoproterenol</a> infusion, or synchronized or unsynchronized cardioversion. Stopping any offending medication, including antipsychotic medications that prolong the QT interval, is paramount. Because up to 10 percent of patients who develop medication-related TdP harbor mutations associated with the long QT syndrome, these patients should be referred to a cardiologist. The management of polymorphic VT is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/936.html" rel="external">"Overview of the acute management of tachyarrhythmias", section on 'Polymorphic ventricular tachycardia'</a> and  <a class="medical medical_review" href="/z/d/html/116011.html" rel="external">"Acquired long QT syndrome: Clinical manifestations, diagnosis, and management"</a>.)</p><p>It is important to avoid giving medications that would further prolong repolarization to the patient with a prolonged QT interval. A list of such drugs can be found in the following table  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 5</a>). In addition to antipsychotics and antidepressants, common medications on this list include <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">amiodarone</a>, <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">clarithromycin</a>, <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a>, <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">methadone</a>, <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a>, and <a class="drug drug_general" data-topicid="9752" href="/z/d/drug information/9752.html" rel="external">pentamidine</a> [<a href="#rid46">46</a>].</p><p>Studies involving patients with the genetically determined congenital long-QT syndrome suggest that prolongation of the absolute (uncorrected) QT interval beyond 500 msec confers an increased risk of TdP. Unfortunately, data correlating the QT interval (absolute or corrected) with the risk of drug induced TdP are lacking, and some evidence is contradictory. A reasonable, conservative approach is to continue monitoring a patient until the heart rate and QTc are no longer in the "at-risk" area of the QT Interval Nomogram, which can be found in the following reference available online [<a href="#rid47">47</a>], or until the Bazett's corrected QTc interval is less than 500 msec and decreasing (<a class="calc calc_professional" href="/z/d/html/13459.html" rel="external">calculator 1</a>).</p><p class="headingAnchor" id="H15"><span class="h2">Anticholinergic delirium</span><span class="headingEndMark"> — </span>All typical antipsychotic medications have anticholinergic (antimuscarinic) properties; overdoses of typical antipsychotic medications occasionally present with anticholinergic delirium. The management of anticholinergic delirium and related symptoms is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/305.html" rel="external">"Anticholinergic poisoning"</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Neuroleptic malignant syndrome</span><span class="headingEndMark"> — </span>Neuroleptic malignant syndrome (NMS) is an uncommon but potentially lethal side effect of antipsychotic medications characterized by mental status change, rigidity, fever, and dysautonomia (eg, labile blood pressure). The management of NMS is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome", section on 'Treatment'</a>.)</p><p>A related condition, neuroleptic induced catatonia, has been described. Neuroleptic induced catatonia resembles NMS, but without fever, and usually responds to benzodiazepines. (See  <a class="medical medical_review" href="/z/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome", section on 'Malignant catatonia'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Extracorporeal removal</span><span class="headingEndMark"> — </span>Because of their lipophilicity, high protein binding, and large volume of distribution, hemodialysis is not useful in the management of antipsychotic medication overdose.</p><p class="headingAnchor" id="H18"><span class="h2">Ongoing treatment and disposition</span><span class="headingEndMark"> — </span>After initial stabilization, care of the patient with typical antipsychotic medication overdose is primarily supportive. Because the elimination half-life of these agents ranges from 6 to 24 hours and the antimuscarinic effects of the drugs can cause prolonged GI absorption, recovery generally takes one to three days. Although occasionally patients wake up quickly enough to be discharged from the emergency department (ED), hospital admission is the rule. Peak clinical effects are usually manifest upon or shortly after arrival to the hospital. Depending upon the nursing and monitoring resources available on inpatient units, patients who remain stable after a period of observation in the ED may not require ICU admission.</p><p>Although most patients who overdose on antipsychotic medications survive the episode, these patients remain at high risk of subsequent mortality due to repeat self-poisoning and violent suicide [<a href="#rid48">48</a>]. After medical stabilization, psychiatric assessment and care are of critical importance.</p><p class="headingAnchor" id="H20"><span class="h1">PEDIATRIC CONSIDERATIONS</span><span class="headingEndMark"> — </span>The manifestations and management of typical antipsychotic medication overdose are the same in children and adults.</p><p>A child who accidentally ingests a dose of a typical antipsychotic medication that is less than the equivalent of the maximum therapeutic dose for a 24 hour period for that child's weight, has no sign of intoxication after a four to six hour period of observation, and has reliable caregivers may be observed at home rather than admitted to the hospital.</p><p>Consultation with a poison control center is strongly recommended in all cases of pediatric overdose. (See <a class="local">'Additional resources'</a> below.)</p><p class="headingAnchor" id="H5184641"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H3040770270"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H4143060153"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span><span class="headingEndMark"> — </span>A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef64216" href="/z/d/graphic/64216.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Great variability exists in the amount of typical antipsychotic medication needed to cause signs and symptoms of overdose. Many patients present obtunded and history is obtained from family, friends, first responders, and pharmacists. Acute extrapyramidal syndromes (EPS), such as akathisia and dystonic reactions, can occur with any dose. (See <a class="local">'History'</a> above and <a class="local">'Acute extrapyramidal syndromes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Typical antipsychotic poisoning does not cause any pathognomonic signs. The range of possible examination findings is described in the text. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have overdosed on antipsychotic medication may be clinically indistinguishable from those who have overdosed on a wide variety of medications with sedative properties (eg, benzodiazepines, anticonvulsants, cyclic antidepressants, atypical antipsychotics), as well as patients with somnolence or delirium from medical causes (eg, hypoglycemia, CNS infection, head trauma). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most patients with a pure antipsychotic medication overdose present with CNS depression and no more than minor vital sign perturbations. These cases are managed with supportive care. Some patients overdose on multiple substances and require airway protection. Hypotension is treated with IV boluses of isotonic fluid. QRS prolongation from acute antipsychotic intoxication is treated with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a>. (See <a class="local">'Airway, breathing, and circulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe complications from typical antipsychotic poisoning rarely occur. Seizures are treated with benzodiazepines. Severe hyperthermia, particularly if it develops in the setting of muscular rigidity, altered mental status, and autonomic instability, raises the specter of neuroleptic malignant syndrome, and should be managed aggressively. (See <a class="local">'General treatment and antidotal therapy'</a> above and  <a class="medical medical_review" href="/z/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although many typical antipsychotic medications prolong the QT interval, torsades de pointes is uncommon. Management of QT prolongation consists of cardiac monitoring and correction of electrolyte disorders, particularly hypokalemia and hypomagnesemia. (See <a class="local">'QT interval prolongation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hampton LM, Daubresse M, Chang HY, et al. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry 2014; 71:1006.</a></li><li><a class="nounderline abstract_t">Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila) 2020; 58:1360.</a></li><li><a class="nounderline abstract_t">Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394:939.</a></li><li><a class="nounderline abstract_t">Sekine Y, Rikihisa T, Ogata H, et al. Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions. Eur J Clin Pharmacol 1999; 55:583.</a></li><li><a class="nounderline abstract_t">White, SR. Acute dystonic reaction and the neuroleptic malignant syndrome. J Pharm Practice 2005; 18:175.</a></li><li><a class="nounderline abstract_t">Crumb WJ Jr, Ekins S, Sarazan RD, et al. Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis. Pharm Res 2006; 23:1133.</a></li><li><a class="nounderline abstract_t">Drolet B, Zhang S, Deschênes D, et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999; 10:1597.</a></li><li><a class="nounderline abstract_t">Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000; 355:1048.</a></li><li><a class="nounderline abstract_t">Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 1995; 33:199.</a></li><li><a class="nounderline abstract_t">Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002; 62:1649.</a></li><li><a class="nounderline abstract_t">Salih IS, Thanacoody RH, McKay GA, Thomas SH. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. Clin Pharmacol Ther 2007; 82:548.</a></li><li><a class="nounderline abstract_t">Di Salvo TG, O'Gara PT. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 1995; 18:285.</a></li><li><a class="nounderline abstract_t">Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158:1774.</a></li><li><a class="nounderline abstract_t">Berling I, Isbister GK. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram. Ann Emerg Med 2015; 66:154.</a></li><li><a class="nounderline abstract_t">Hazell L, Raschi E, De Ponti F, et al. Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project. J Clin Pharmacol 2017; 57:558.</a></li><li><a class="nounderline abstract_t">Arita M, Nagamoto Y, Saikawa T. Intraventricular conduction disturbance due to delayed recovery from ventricular inactivation in chlorpromazine-treated dogs. Recent Adv Stud Cardiac Struct Metab 1976; 11:85.</a></li><li><a class="nounderline abstract_t">Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 1989; 97:905.</a></li><li><a class="nounderline abstract_t">Ogata N, Yoshii M, Narahashi T. Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells. J Physiol 1990; 420:165.</a></li><li><a class="nounderline abstract_t">Enyeart JJ, Dirksen RT, Sharma VK, et al. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart. Mol Pharmacol 1990; 37:752.</a></li><li><a class="nounderline abstract_t">Sykes DA, Moore H, Stott L, et al. Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nat Commun 2017; 8:763.</a></li><li><a class="nounderline abstract_t">Nguyen TT, Pariente A, Montastruc JL, et al. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders. Br J Clin Pharmacol 2017; 83:612.</a></li><li><a class="nounderline abstract_t">Van Putten T, Gelenberg AJ, Lavori PW, et al. Anticholinergic effects on memory: benztropine vs. amantadine. Psychopharmacol Bull 1987; 23:26.</a></li><li><a class="nounderline abstract_t">Kubo S, Orihara Y, Kitamura O, et al. An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria. Forensic Sci Int 2001; 115:155.</a></li><li><a class="nounderline abstract_t">Martin DT, Swash M. Muscle pathology in the neuroleptic malignant syndrome. J Neurol 1987; 235:120.</a></li><li><a class="nounderline abstract_t">Caroff SN, Rosenberg H, Fletcher JE, et al. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anesthesiology 1987; 67:20.</a></li><li><a class="nounderline abstract_t">Peacock J, Whang W. Antipsychotic medications and sudden cardiac arrest: more than meets the eye? Heart Rhythm 2013; 10:531.</a></li><li><a class="nounderline abstract_t">Tromeur C, Couturaud F. Antipsychotic drugs and venous thromboembolism. Thromb Res 2012; 130 Suppl 1:S29.</a></li><li><a class="nounderline abstract_t">Weeke P, Jensen A, Folke F, et al. Antipsychotics and associated risk of out-of-hospital cardiac arrest. Clin Pharmacol Ther 2014; 96:490.</a></li><li><a class="nounderline abstract_t">Lopez OL, Becker JT, Chang YF, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry 2013; 170:1051.</a></li><li><a class="nounderline abstract_t">Gardette V, Lapeyre-Mestre M, Coley N, et al. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. Curr Alzheimer Res 2012; 9:1106.</a></li><li><a class="nounderline abstract_t">Bloechliger M, Rüegg S, Jick SS, et al. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis. CNS Drugs 2015; 29:591.</a></li><li><a class="nounderline abstract_t">Packard K, Price P, Hanson A. Antipsychotic use and the risk of rhabdomyolysis. J Pharm Pract 2014; 27:501.</a></li><li><a class="nounderline abstract_t">Masi G, Milone A, Viglione V, et al. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature. J Child Adolesc Psychopharmacol 2014; 24:536.</a></li><li><a class="nounderline abstract_t">Isah AO, Rawlins MD, Bateman DN. Clinical pharmacology of prochlorperazine in healthy young males. Br J Clin Pharmacol 1991; 32:677.</a></li><li class="breakAll">Klasco, RK (Ed): DRUGDEX® System, Vol. 136. Thomson Healthcare, Greenwood Village, Colorado (Edition expires 6/2008).</li><li><a class="nounderline abstract_t">Drotts DL, Vinson DR. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med 1999; 34:469.</a></li><li><a class="nounderline abstract_t">Juncal-Ruiz M, Ramirez-Bonilla M, Gomez-Arnau J, et al. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment. Psychopharmacology (Berl) 2017; 234:2563.</a></li><li class="breakAll">Canadian Movement Disorders Group. Acute Dystonic Reaction. www.cmdg.org/Movement_/drug/Acutedystonicreaction/acutedystonicreaction.htm (Accessed on October 15, 2008).</li><li><a class="nounderline abstract_t">Meulendijks D, Mannesse CK, Jansen PA, et al. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010; 33:101.</a></li><li><a class="nounderline abstract_t">Jiang Y, McCombs JS, Park SH. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS Drugs 2017; 31:319.</a></li><li><a class="nounderline abstract_t">Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S829.</a></li><li><a class="nounderline abstract_t">König P, Chwatal K, Havelec L, et al. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders. Neuropsychobiology 1996; 33:80.</a></li><li><a class="nounderline abstract_t">Adler L, Angrist B, Peselow E, et al. A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia. Br J Psychiatry 1986; 149:42.</a></li><li><a class="nounderline abstract_t">Stryjer R, Rosenzcwaig S, Bar F, et al. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study. Clin Neuropharmacol 2010; 33:219.</a></li><li><a class="nounderline abstract_t">Choy AM, Lang CC, Chomsky DM, et al. Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation 1997; 96:2149.</a></li><li class="breakAll">Combined list of drugs that prolong QT and/or cause torsades de pointes (TdP). AZCERT. Available at: https://crediblemeds.org/pdftemp/pdf/CombinedList.pdf (Accessed on November 29, 2020).</li><li><a class="nounderline abstract_t">Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609.</a></li><li><a class="nounderline abstract_t">Toft S, Horwitz H, Dalhoff KP. Long-term mortality after poisoning with antipsychotics. Clin Toxicol (Phila) 2017; 55:267.</a></li></ol></div><div id="topicVersionRevision">Topic 315 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25006837" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Emergency department visits by adults for psychiatric medication adverse events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33305966" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31303314" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10541776" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acute dystonic reaction and the neuroleptic malignant syndrome</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16715368" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10636190" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744090" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760442" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cardiotoxicity more common in thioridazine overdose than with other neuroleptics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12109926" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17410120" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7628136" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11691681" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25639523" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28019033" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1031966" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intraventricular conduction disturbance due to delayed recovery from ventricular inactivation in chlorpromazine-treated dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2547491" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2157837" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2160063" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28970469" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27687785" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3602326" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Anticholinergic effects on memory: benztropine vs. amantadine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11056287" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3430190" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Muscle pathology in the neuroleptic malignant syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3605730" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23276816" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Antipsychotic medications and sudden cardiac arrest: more than meets the eye?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23026655" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Antipsychotic drugs and venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24960522" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Antipsychotics and associated risk of out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23896958" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22950915" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26242478" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24429293" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Antipsychotic use and the risk of rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25387323" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1768559" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Clinical pharmacology of prochlorperazine in healthy young males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1768559" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Clinical pharmacology of prochlorperazine in healthy young males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10499947" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prochlorperazine induces akathisia in emergency patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28567698" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28567698" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20082537" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28290080" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956228" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8927233" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2877708" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20838215" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9337183" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Normalization of acquired QT prolongation in humans by intravenous potassium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9337183" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Normalization of acquired QT prolongation in humans by intravenous potassium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17881416" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28152633" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Long-term mortality after poisoning with antipsychotics.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
